stockrowPrivia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +83.3%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
Follow PRVA
Alert me
Privia Health Group, Inc. (PRVA) Return on assets
Privia Health Group, Inc.'s return on assets over the twelve months to 30 September 2026 was 2.38%, up 0.6 percentage points from fiscal 2025 (1.83%). Over the past ten years it has ranged from −37.1% (fiscal 2021) to 19.0% (fiscal 2020); the current reading is higher than 75% of that period. That is above the Health Information Services industry median of −5.62% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 1.83% | 0.48 |
| FY2024 | 1.35% | (1.22) |
| FY2023 | 2.57% | 3.73 |
| FY2022 | −1.16% | 35.92 |
| FY2021 | −37.1% | (56.08) |
| FY2020 | 19.0% | 19.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | — |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| DOCS Doximity, Inc. compare | 11.9% |
| WAY Waystar Holding Corp. compare | 2.53% |
| PRVA Privia Health Group, Inc. | 2.38% |
| OMCL Omnicell, Inc. compare | 2.23% |
| GDRX GoodRx Holdings, Inc. compare | 0.89% |
| CERT Certara, Inc. compare | −4.36% |
| TDOC Teladoc Health, Inc. compare | −5.48% |
| SDGR Schrodinger, Inc. compare | −9.36% |
| HTFL Heartflow, Inc. compare | −47.0% |
| Health Information Services industry median | −5.62% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on PRVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement